— Know what they know.
Not Investment Advice

AIDX NASDAQ

20/20 Biolabs Inc.
1W: -12.1% 1M: -23.7% 3M: -72.5% YTD: -98.1%
$0.46
+0.00 (+1.07%)
After Hours: $0.47 (+0.01, +2.64%)
Weekly Expected Move ±9.9%
$0 $0 $0 $1 $1
NASDAQ · Healthcare · Medical - Care Facilities · Alpha Radar Sell · Power 39 · $2.6M mcap · 4M float · 18.47% daily turnover · Short 28% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.6M
52W Range0.4305-50
Volume102,362
Avg Volume790,687
Beta1.80
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOJonathan Cohen
Employees14
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date2026-02-19
15810 Gaither Road
Gaithersburg, MD 20877
US
(240) 453-6339
About 20/20 Biolabs Inc.

20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.

Recent Insider Trades

NameTypeSharesPriceDate
Bergman Alan B. A-Award 100,000 $1.88 2026-04-02
Zhou Jiming A-Award 150,000 $1.88 2026-04-02
Cohen Jonathan M A-Award 352,936 $3.39 2026-03-03

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms